Edwards Lifesciences EW
NYSE EW
$86.17 -0.55 (-0.63%)
As of: Sep 9, 2026 · 12:14 PM EDT

Edwards Lifesciences (EW) EBT Margin Growth (3y) (2012 - 2026)

Analysis

Edwards Lifesciences (EW) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 184.10 Bn 178.50 Bn 7.27 Bn -429.00
2 Intuitive Surgical 124.21 Bn 118.99 Bn 1.96 Bn 803.00
3 Medtronic 118.33 Bn 109.51 Bn 6.34 Bn 260.00
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 574.00
5 Boston Scientific 66.39 Bn 65.86 Bn 3.85 Bn 764.00
6 Edwards Lifesciences 49.69 Bn 45.43 Bn 1.35 Bn 835.00
7 Alcon 33.94 Bn 32.48 Bn 1.68 Bn -1,045.00
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 598.00
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn 423.00
10 Zimmer Biomet Holdings 18.14 Bn 17.73 Bn 1.54 Bn -309.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 835.00
Mar 31, 2026 -480.00
Dec 31, 2025 -4,341.00
Sep 30, 2025 -845.00
Jun 30, 2025 -770.00
Mar 31, 2025 -180.00
Dec 31, 2024 -15.00
Sep 30, 2024 -10.00
Jun 30, 2024 -1,160.00
Mar 31, 2024 -409.00
Dec 31, 2023 -89.00
Sep 30, 2023 -76.00
Jun 30, 2023 3,969.00
Mar 31, 2023 34.00
Dec 31, 2022 2,230.00
Sep 30, 2022 330.00
Jun 30, 2022 886.00
Mar 31, 2022 452.00
Dec 31, 2021 2,848.00
Sep 30, 2021 240.00